Guest guest Posted December 24, 2004 Report Share Posted December 24, 2004 http://www.blackwell-synergy.com/links/doi/10.1111/j.1439- 0329.2004.00356.x/full/ 3.3 Is dothistromin a human health risk? The structural similarity of dothistromin to aflatoxins prompted serious concerns about the health risk associated with Dothistroma needle blight, especially for forest workers. Aflatoxin B1 is the most potent naturally occurring carcinogen known ( Squire 1989) and is classified as a group I carcinogen by the International Agency for Research on Cancer. It is also teratogenic (causing deformities in embryos) and toxic. Cancer research with animals showed that a minimum dose of 50 ng aflatoxin B1/kg body weight/day is necessary to produce tumours, whilst toxicology studies with humans exposed to dietary aflatoxins have suggested the acute lethal dose of aflatoxin B1 for adults is 1020 mg ( Elliott et al. 1989; and Klich 2003). Aflatoxins are activated to more potent forms by microsomal enzymes. Cytochrome P450 enzymes convert the unsaturated bisfuran ring of aflatoxin B1 to the highly carcinogenic 8,9-epoxide form that can bind to DNA ( Eaton and Gallagher 1994). Recent work by our group in collaboration with Dr D. Bhatnagar's aflatoxin group (New Orleans SRRC, USDA) has shown no evidence for aflatoxin production by D. pini but the acute toxicity and potential genotoxicity of dothistromin remains a concern. Table 3 summarizes dothistromin toxicology studies that have been carried out with a wide range of organisms and cell types. The reader is also referred to the comprehensive summary of published and unpublished work on this topic by Elliott et al. (1989). Toxicity has been measured by growth inhibition, cell lysis and mitotic index. Dothistromin is toxic to P. radiata tissue at low concentrations, but is also highly toxic to a range of bacterial, fungal, plant, animal and human cells (Table 3). In most studies light was required for toxicity, but the brine shrimp Artemia salina was susceptible to the effects of dothistromin without light activation ( Stoessl et al. 1990). Compared with aflatoxin B1, dothistromin appeared to have higher toxicity to Bacillus megaterium, with concentrations of 510 g/ml aflatoxin B1 but only 0.51.0 g/ml dothistromin required to completely inhibit growth ( Harvey et al. 1976). However, when a direct comparison of these toxins was made with human lymphocytes using mitotic index as a measure of toxicity, there was little difference between them ( Ferguson et al. 1986), although when aflatoxin was metabolically activated it caused a significant depression of mitotic index (suggesting higher toxicity) compared with that seen with dothistromin. Does dothistromin cause damage to genetic material and is it a carcinogen? There have been no epidemiological studies reported to date that suggest it is a carcinogen: reviews of cancer incidence in forestry workers showed no evidence to connect dothistromin with lung cancer ( Elliott et al. 1989). However, there is evidence that dothistromin is a weak mutagen and clastogen. Dothistromin showed significant mutagenic activity in an Ames assay ( Ferguson 1986; Elliott et al. 1989) and in a screen for specific induced mutations in Chinese hamster fibroblasts (McLarin and Ferguson 1985) but mutagenic activity was weak compared with aflatoxin B1. In both cases, it appears that metabolic activation enhanced mutagenicity but unfortunately the details of these studies were not published. Clastogenic activity of dothistromin has also been demonstrated with tests for chromosome aberrations and sister-chromatid exchange (SCE) in human cells and with micronucleus assays in rodent cells (McLarin and Ferguson 1985; Ferguson et al. 1986; Elliott et al. 1989; Skinnider et al. 1989). Chromosome aberrations caused by dothistromin were mostly simple gaps and deletions and were not affected by metabolic activation, whilst aflatoxin B1 (with metabolic activation) induced a higher level of aberrations at equivalent doses, with more complex exchange type aberrations. Similarly the effect of dothistromin as demonstrated by the micronucleus assay with Chinese hamster cells, was weak compared with aflatoxin B1 and was not dependent on metabolic activation (McLarin and Ferguson 1985). In a study of SCE induced by dothistromin in human cells, Skinnider et al. (1989) made the interesting observation that purified lymphocytes show a greatly enhanced sensitivity to dothistromin compared with lymphocytes in whole blood (a threefold increase in SCE with only 1/10 the concentration of dothistromin). This effect was not seen with the mitomycin control and it was therefore postulated that dothistromin may be 'neutralized' by some component in whole blood. There is clearly a lot more to discover about the complexities of how dothistromin might act in vivo. The only in vivo study on mammals reported in the literature showed an equivalent clastogenic effect of dothistromin and aflatoxin ( Elliott et al. 1989) although the increases in clastogenicity seen with these toxins were not significantly greater than a toxin-free control. The authors attributed this lack of statistical significance partly to the genetic diversity of the mice used in the study. Because dothistromin is highly toxic to a wide range of cell types at low doses it appears that there is a narrow difference between effective doses for mutagenicity/clastogenicity and toxicity, with, in effect, cells being killed before their genetic material is damaged. Ferguson et al. (1986) wrote that the 'toxicity may be masking any major potential for clastogenicity by dothistromin'. In summary, there is evidence that dothistromin is a weak mutagen and clastogen in mammals, although at higher doses there is more likely to be toxicity to cells rather than an increased risk of genetic damage. Research from the New Zealand Forest Research Institute (NZFRI) and Department of Health indicated low levels (<7 ng/ml) of dothistromin in air and water from the catchment area of forests with Dothistroma blight (documented by Elliott et al. 1989). Dothistromin levels are higher in wet periods than in dry, and are higher at certain times of the year such as during the summer when the fungus is most active ( Briggs 1985; Ferguson 2002). The exposure of forestry workers involved in thinning, low pruning or final clear felling of pine trees with 2340% mean Dothistroma disease rate was monitored by measuring dothistromin levels in the air, on clothing and on skin ( Briggs 1985). Although low but quantifiable levels of toxin were detected, there was a wide variation even between workers carrying out the same job on the same day, for example, air filtered from the breathing zone of two workers engaged in pruning contained <0.0009 and 0.1493 ng/ l dothistromin. This variation could be accounted for by the collection of a few particles (such as needle fragments) containing relatively high levels of dothistromin, rather than the collection of many particles with low toxin content. Despite the generally accepted low risk to forestry workers nonetheless it is prudent to limit exposure. The New Zealand Dothistroma Control Advisory Committee ( Anonymous 1986) advised the following (reproduced with permission from the NZ Farm Forestry Association): In dry conditions there is a negligible risk of exposure to dothistromin. In wet stands the recorded incidence of dothistromin was higher but still too low to confirm a real exposure risk to workers. Wherever practical, work should be scheduled away from infected stands during wet weather. It is important to ensure workers wear protective clothing when working in infected stands in wet weather. It is important to correctly implement the spray programme recommended by the Disease Control Advisory Committee (all stands with disease level above 15% and in which workers will be operating over the next 12 months are to be sprayed). Further advice given by Briggs (1985) includes: Forestry workers should wear clothing that does not collect dothistromin-containing particles: cotton is preferable to wool. Work clothes should be washed frequently and exposed areas of the body such as hands, face and hair should be kept clean to prevent accumulation of dothistromin-containing particles. Disposable dust masks should be supplied for use by workers. However, note that, in New Zealand, after decades of coping with Dothistroma needle blight in commercial forests these practices are not adhered to rigorously nowadays as there has been no evidence of detrimental effects on forestry workers. http://www.biomedcentral.com/news/20041223/01/ December 23, 2004 Previous | Next Spreading fungus, not cheerIncrease of red band needle blight means that Christmas tree may not be quite so pretty | By Branwen Not everyone wants a real Christmas tree—after all, they only last one season and make a mess with all that dropped foliage—but many do like to have the choice. Unfortunately, levels of Dothistroma pini, a toxic fungus that causes red banded lesions on pine needles and premature defoliation, could affect such decisions. A number of countries in the Northern hemisphere, including the United Kingdom, France, and Canada are reporting an upsurge in the severity and distribution of D. pini infection. Milder and wetter weather conditions are partly to blame, as the spread of this pathogen is favored under moist, warm, light, and sheltered conditions. Brown, who heads the Dothistroma Project at Forest Research, UK, told The Scientist: " This disease has become particularly noticeable over the past 2 years and has apparently been increasing in frequency for 5 to 6 years. In the 2002–2003 period, we found over a quarter of the trees were suffering serious defoliation in the East Anglia forest district, where large numbers of the highly susceptible Corsican pine are planted. " New Zealand and Australia have been coping with widespread D. pini infection for decades and have been quite successful in protecting their pine forests. The fungus rarely kills the tree, but the percentage of pine needles infected is directly proportional to loss of wood yield, so D. pini can have a severe economic impact. One new approach that could be fruitful is to genetically engineer trees that inactivate, remove, or prevent synthesis of toxin by the fungus. The toxin, dothistromin, is thought to be the primary cause of red band needle blight and is structurally related to the potent carcinogen aflatoxin, produced by some fungi from the genus Aspergillus. This similarity has enabled scientists to identify and isolate key genes involved in the synthesis pathway. Rosie Bradshaw, from Massey University in New Zealand, is one of a small number of researchers worldwide who is focusing her efforts on taming the feisty fungus. Her team has knocked out some of the genes that are essential for synthesizing dothistromin. " We now have the means to determine if dothistromin is responsible for pathogenicity and are currently trying to infect whole pine needles, before trying seedlings in the lab. We also have GFP reporter strains, so we'll be able to track where and when the dothistromin genes are expressed. If dothistromin production is essential, it will be a good target for disease control, " she told The Scientist. One option would be to use non–toxin-producing strains as biocontrol competitors with the toxigenic fungi in the field. Others include engineering trees that express dothistromin-specific antibodies in the needles or targeting destruction of the toxin in the plant tissue by enzymatic means. Another approach is the deployment of toxin transporter genes into host plants. These transporters are normally used by the fungus to allow secretion into plant tissue and to provide a self-protection mechanism against the effects of its own toxin. Bradshaw has already isolated a candidate dothistromin transporter from D. pini that could be used in this way. Bradshaw acknowledged that genetic modification of trees is not necessarily the best option for disease management. " But in the long term, it may well be our detailed knowledge of the molecular biology of the pathogen and its toxin that will provide the basis for sustainable control, " she said. So, where does that leave the Christmas shoppers who want nothing more than a glass of mulled wine and a pine tree to decorate? " I would think people probably wouldn't buy a tree with Dothistroma simply because they aren't very pretty—unless you're a pathologist, " said Woods, a regional forest pathologist in British Columbia, one of the areas worst affected. " That said, I did notice an advertisement for Wal-Mart of people picking out pine Christmas trees that all looked pretty badly defoliated by a foliar disease, and they only had the current years growth on them... Seriously! But I guess only a pathologist would have seen that. " Links for this article R.E. Bradshaw, " Dothistroma (red-band) needle blight of pines and the dothistromin toxin: a review. " Forest Pathology, 34:163-85, June 2004. http://www.blackwell-synergy.com/links/doi/10.1111/j.1439-0329. 2004.00356.x/full/ Rosie Bradshaw http://imbs.massey.ac.nz/Staff/bradshaw.html P. Smaglik, " Biocontrols: an alternative to pesticides? " The Scientist, October 12, 1998. http://www.the-scientist.com/1998/10/12/1/3 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.